ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Cancer Screening Molecular Tools

Fengting Yan

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

Recent FDA Indications in Endometrial Cancers

Brian Slomovitz

2024 Updates in Ovarian Cancer

Total Health

T. Tillmanns

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

2024 ASCO® Annual Meeting Insights Hub

A. Karam

ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Adva…

2024 ESMO Annual Meeting Insights Hub

M. Raza Mirza

SGO 2024 Summary: "Key Updates in Endometrial Cancer"

Insights from 2024 SGO Annual Meeting

M. Raza Mirza

SGO 2024 Insights: "GOG-0258 - OS by Molecular Classification With a…

Insights from 2024 SGO Annual Meeting

A. Clements

Defining Platinum Resistance in Ovarian Cancer

Michael Birrer

2024 Updates in Cervical Cancer

Total Health

T. Tillmanns

Management of Recurrent Ovarian Clear Cell Carcinoma

David Tan

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Insights from 2023 ESMO Annual Meeting

M. Raza Mirza

Updates in the Management of Cervical Cancer

Abdulrahman Sinno

ESMO 2024 Insights: Pembro or Placebo in Combination With Adjuvant C…

2024 ESMO Annual Meeting Insights Hub

B. Slomovitz

SGO 2024 Endometrial Cancer Highlights

Insights from 2024 SGO Annual Meeting

P. Binder

Classification, Diagnosis and Treatment of Endometrial Cancer in 2024

Yale Cancer Center

P. Dottino

Endometrial Cancer: The Current Treatment Landscape

Hope Cottrill